We read with great interest C. S. Antonio et al.'s letter describing the high prevalence of Acinetobacter baumannii carrying bla in Brazilian hospitals (1). Recently, we carried out a similar study, and although the bla OXA-143 gene was identified, its frequency was lower than that reported by Antonio et al. (1).
bla OXA-143 gene (58.3%), we found that only 7 of 83 (8.4%) A. baumannii isolates carried this gene. These isolates were collected from a few hospitals located in the cities of São Paulo (n ϭ 6) and Rio de Janeiro (n ϭ 1). In both studies, the majority of OXA-143-producing A. baumannii isolates were recovered from cities located in São Paulo State. However, while Antonio et al. observed that 70% (21/30) of the isolates from this region carried the bla OXA-143 gene, in the present study, we identified this resistance determinant in only 20.7% (6/29) of isolates collected from São Paulo. Moreover, we have observed the predominance of a single PFGE clone among the seven OXA-143-producing A. baumannii isolates, which contrasts with results obtained by Antonio et al., in which 7 distinct enterobacterial repetitive intergenic consensus sequence (ERIC) PCR clones harbored the bla OXA-143 gene. Nevertheless, in their study, the high prevalence of OXA-143-producing isolates could also be partially justified by the intrahospital spread of a single clone, which corresponded to 57.1% of all OXA-143-producing isolates (1) . The high prevalence of bla OXA-23 found in our study may also be justified by intra-and interhospital spread of endemic clones. The results of these two studies show that the prevalence of CHDLs may vary according to the disseminated clone in a specific hospital or region and emphasize the importance of appropriate adherence to infection control measures. Thus, wide national surveillance studies are necessary to analyze the real prevalence of CHDLs in Brazilian hospitals.
